Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Brain and Central Nervous System Tumors
Related studies linked through entity extraction aliases.
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
- Status
- TERMINATED
- Phase
- NA
Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
- Status
- COMPLETED
- Phase
- PHASE3
Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma
- Status
- TERMINATED
- Phase
- NA
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma
- Status
- UNKNOWN
- Phase
- PHASE2
Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors
- Status
- WITHDRAWN
- Phase
- NA
MT2004-30: Tomotherapy for Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Rosiglitazone in Treating Patients With Pituitary Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Temozolomide in Treating Patients With Invasive Pituitary Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer
- Status
- TERMINATED
- Phase
- PHASE1
CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
- Status
- UNKNOWN
- Phase
- PHASE2